Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1994-07-01
1997-02-04
Ulm, John
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 12, 514885, 514886, 514887, 514944, 514945, 514946, 514947, 424409, 4242781, A61K 910, C07K 1708
Patent
active
055997880
ABSTRACT:
A method of producing recombinant transforming growth factor .beta.-induced H3 protein and the use of this protein to accelerate wound healing. H3 promoted adhesion of human dermal fibroblasts to tissue culture plastic. The protein is applied directly to a wound or is used to promote adhesion and spreading of dermal fibroblasts to a solid support such as a nylon mesh which is then applied to the wound. In addition, CHO cells expressing H3 inhibited tumor cell growth.
REFERENCES:
patent: 4721096 (1988-01-01), Naughton et al.
patent: 4963489 (1990-10-01), Naughton et al.
patent: 5444164 (1995-08-01), Purchio et al.
Mustoe et al. (1987) Science vol. 237 pp. 1333-1335.
Jones et al. (1991) J. of Surgical Res. vol. 51 pp. 344-352.
Le Baron et al. (1995) J. Invest. Dermatol. vol. 104, pp. 844-849.
Agrez, M. et al. (1991) Arg-Gly-Asp-containing peptides expose novel collagen receptors on fibroblasts: implications for wound healing. Cell Regulation 2:1035-1044.
Barnard, J. et al. (1990) The cell biology of transforming growth factor .beta.. Biochimica et Biophysica Acta 1032:79-87.
Bebbington, C. R. et al. (1992) High-level expression of a recombinant antibody from myeloma cells using a glutamine synthetase gene as an amplifiable selectable marker. Biotechnology 10:169-175.
Cate, R. L. et al. (1986) Isolation of the bovine and human genes for M ullerian inhibiting substance and expression of the human gene in animal cells. Cell 45:685-698.
Cockett, M. I. et al. (1990) High level expression of tissue inhibitor of metalloproteinases in chinese hamster ovary cells using glutamine synthitase gne amplification. Biotechnology 8:662-667.
Dustin, M. et al. (1989) T-cell receptor cross-linking transiently stimulates adhesiveness through LFA-1. Nature 341:619-624.
Gentry, L. et al. (1988) Molecular events in the processing of recombinant type 1 pre-pro-transfering growth factor beta to the mature polypeptide. Molecular and Cellular Biology 8(10):4162-4168.
Goey, H. et al. (1989) Inhibition of early murine hemopoietic progenitor cell proliferation after in vivo locoregional administration of transforming growth factor-.beta.1.sup.1. The Journal of Immunology 143(3):877-880.
Graf, J. et al. (1987) Identification of an amino acid sequence in laminin mediating cell attachment chemotaxis, and receptor binding. Cell 48:989-996.
Hemler, Martin E. (1990) VLA proteins in the integrin family: structures, functions, and their role on leukocytes.sup.1. Annu. Rev. Immunol. 8:365-400.
Hynes, Richard O. (1992) Integrins: versatility, modulation, and signaling in cell adhesion. Cell. 69:11-25.
Ignotz, R. et al. (1986) Transforming growth factor-.beta. stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix*. The Journal of Biological Chemistry 261(9):4337-4345.
Landegren, Ulf (1984) Measurement of cell numbers by means of the endogenous enzyme hexosaminidase. Applications to detection of lymphokines and cell surface antigens. Journal of Immunological Methods 67:379-388.
Mason, A. et al. (1985) Complementary DNA sequences of ovarian follicular fluid inhibin show precursor structure and homology with transforming growth factor-.beta.. Nature 318:659-663.
Matsudaira, Paul (1987) Sequence from picomole quantities of proteins electroblotted onto polyvinylidene difluoride membranes*. The Journal of Biological Chemistry 262(21):10035-10038.
Mustoe, T. et al. (1987) Accelerated healing of incisional wounds in rats induced by transforming growth factor-.beta.. Science 237:1333-1335.
Noda, M. et al. (1989) In vivo stimulation of bone formation by transforming growth factor-.beta.. Endocrinology 124(6):2991-2994.
Pietenpol, J. et al. (1990) Transforming growth factor .beta.1 suppression of c-myc gene transcription: role in inhibition of keratinocyte proliferation. Proc. Natl. Acad. Sci. 87:3758-3762.
Quaglino Jr., D. et al. (1991) Transforming growth factor-beta stimulates wound healing and modulates extracellular matrix gene expression in pig skin: incisional wound model. J. Invest. Dermatol. 97:34-42.
Ruoslahti, Erkki (1991) Integrins. J. Clin. Invest. 87:1-5.
Skonier, J. et al. (1992) cDNA cloning and sequence analysis of .beta.ig-h3, a novel gene induced in a human adenocarcinoma cell line after treatment with transforming growth factor-.beta.. DNA and Cell Biology 11(7):511-522.
Warren, W. et al. (1992) Tissue repair by thrombin-derived peptides in the rat. Peptide Research 5(6):331-335.
Chen, T., et al. (1992) Human recombinant transforming growth factor-.beta.1 modulation of biochemical and cellular events in healing of ulcer wounds. The Journal of Investigative Dermatology 98:428-435.
Zioncheck, T., et al. (1994) Pharmacokinetics and tissue distribution of recombinant human transforming growth factor beta.sub.1 after topical and intravenous administration in male rats. Pharmaceutical Research 11(2):213-220.
LeBaron Richard
Purchio Anthony F.
Advanced Tissue Sciences
Mertz Prema
Ulm John
LandOfFree
Method for accelerating skin wound healing with H3 protein does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for accelerating skin wound healing with H3 protein, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for accelerating skin wound healing with H3 protein will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-678601